Arteris (NASDAQ:AIP) COO Laurent Moll Sells 5,600 Shares of Stock

Arteris, Inc. (NASDAQ:AIP) COO Laurent Moll sold 5,600 shares of the business’s stock in a transaction dated Friday, October 2nd. The stock was sold at an average price of $24.64, for a total transaction of $137,984.00. Following the transaction, the chief operating officer owned 206,878 shares in the company, valued at approximately $5,097,473.92. This trade represents a 2.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Arteris Stock Up 0.7%

AIP stock traded up $0.16 during trading on Tuesday, reaching $24.13. The stock had a trading volume of 476,272 shares, compared to its average volume of 728,847. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.03. The company has a market capitalization of $1.19 billion, a price-to-earnings ratio of -27.74 and a beta of 1.90. The company’s 50 day moving average is $24.73 and its two-hundred day moving average is $28.61. Arteris, Inc. has a one year low of $12.06 and a one year high of $50.26.

Arteris (NASDAQ:AIP) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.06). The business had revenue of $24.13 million for the quarter, compared to the consensus estimate of $23.48 million. Arteris had a negative return on equity of 295.96% and a negative net margin of 46.70%. Equities research analysts forecast that Arteris, Inc. will post -0.68 EPS for the current year.

Institutional Investors Weigh In On Arteris

Several large investors have recently added to or reduced their stakes in the business. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Arteris during the 2nd quarter valued at about $53,000. Versant Capital Management Inc raised its position in shares of Arteris by 33.7% during the 2nd quarter. Versant Capital Management Inc now owns 1,150 shares of the company’s stock valued at $56,000 after buying an additional 290 shares in the last quarter. Allworth Financial LP bought a new stake in shares of Arteris during the 2nd quarter worth $87,000. State of Wyoming bought a new stake in shares of Arteris during the 2nd quarter worth $165,000. Finally, Royal Bank of Canada grew its position in Arteris by 366.7% in the first quarter. Royal Bank of Canada now owns 4,023 shares of the company’s stock worth $66,000 after acquiring an additional 3,161 shares in the last quarter. Institutional investors own 64.36% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. Rosenblatt Securities restated a “buy” rating and set a $38.00 price target on shares of Arteris in a research note on Friday, August 7th. Roth Capital assumed coverage on Arteris in a research report on Tuesday, August 4th. They issued a “buy” rating and a $40.00 target price for the company. Jefferies Financial Group raised Arteris from a “hold” rating to a “buy” rating and upped their price target for the company from $35.00 to $50.00 in a research report on Friday, August 7th. Weiss Ratings upgraded Arteris from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, August 21st. Finally, Oppenheimer started coverage on Arteris in a report on Thursday, July 16th. They issued an “outperform” rating and a $40.00 price objective for the company. Six investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $39.43.

Key Stories Impacting Arteris

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris won an additional $3.3 million through the Trusted and Assured Microelectronics program to expand its third-party semiconductor IP security-assurance efforts. The company is collaborating with BAE Systems and SiFive, potentially strengthening its position in defense-related and trusted-chip supply chains. Arteris funding announcement
• Neutral Sentiment: CEO K. Charles Janac and Vice President Paul Alpern sold shares, but the filings state the transactions were made to cover tax withholding obligations related to vested equity awards. Because these were tax-related sales rather than clearly discretionary trades, they provide a limited signal about management’s outlook. SEC filing for executive share sales
• Negative Sentiment: Major shareholder Bayview Legacy LLC sold 100,000 shares for approximately $2.38 million, reducing its ownership by 1.22%. The filing did not cite tax withholding as the reason, so the sale could create modest supply pressure and raise concerns about near-term shareholder confidence. SEC filing for Bayview Legacy share sale

About Arteris

Arteris, Inc is a semiconductor intellectual property (IP) company that develops technologies used in the design of system-on-chip (SoC) devices. Its products help semiconductor and electronics companies connect, manage and protect the various processing, memory and other functional components integrated into complex chips.

The company’s portfolio includes network-on-chip (NoC) interconnect IP, which supports communication among different elements within an SoC, as well as cache-coherent interconnect, system IP and related design technologies.